Ivermectin - FLCCC I-MASK+ Protocol for COVID-19 (June 2022)
EARLY TREATMENT PROTOCOL June 20, 2022
Based on recent clinical experience treating Omicron patients, the Front Line COVID-19 Critical Care Alliance (FLCCC) modified its early treatment protocol to include hydroxychloroquine as "preferred for Omicron".
The Omicron variant of the SARS-CoV-2 virus apparently enters human cells differently than do other variants. Analysis of biological mechanisms for hydroxychloroquine indicate that it has enhanced efficacy for the early treatment of Omicron, especially when coupled with zinc.
For early outpatient protocol (COVID-19 positive), the Front Line COVID-19 Critical Care Working Group, FLCCC I-MASK+ protocol recommends:
1. First line agents (use any or all medicines; listed in order of priority/importance)
Anti-Virals
• Ivermectin: 0.4–0.6 mg/kg per dose (take with or after meals) — one dose daily, take for 5 days or until recovered. Use upper dose range if: 1) in regions with more aggressive variants (e.g. Delta); 2) treatment started on or after day 5 of symptoms or in pulmonary phase; or 3) multiple comorbidities/risk factors.
• Hydroxychloroquine (preferred for Omicron): 200mg PO twice daily; take for 5 days or until recovered.
